A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503948-13-00

Enrollment

105

Registered

2023-07-12

Start date

2023-07-20

Completion date

Unknown

Last updated

2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Post-menopausal women.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Czechia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026